{
    "hands_on_practices": [
        {
            "introduction": "Primary prevention aims to reduce disease incidence by addressing its root causes. A key task in public health is to quantify the potential impact of removing a specific risk factor from a population. This exercise guides you through the derivation of the Population Attributable Fraction (PAF), a fundamental metric used to estimate the maximum proportion of disease cases that could be prevented by eliminating an exposure, thereby informing health policy and intervention priorities .",
            "id": "4380187",
            "problem": "A regional health department is assessing the impact of a primary prevention strategy aimed at eliminating current cigarette smoking on the incidence of cardiovascular disease (CVD). In the adult population under study, the prevalence of current smoking is $p_e = 0.25$, and the relative risk (RR) of incident CVD among smokers compared with nonsmokers is $RR = 2.0$. Assume the following foundational conditions hold: the relative risk is causal and transportable to the target population, there is no confounding or selection bias, and eliminating smoking would set each individual’s risk to the counterfactual unexposed risk.\n\nUsing only core epidemiologic definitions of incidence, exposure prevalence, and relative risk, start from first principles to derive an expression for the Population Attributable Fraction (PAF), defined as the proportionate reduction in population incidence that would occur if the exposure were removed, and then compute the numeric value of $PAF$ for the given $p_e$ and $RR$.\n\nFinally, state in words how a complete primary prevention program that eliminates smoking relates the computed $PAF$ to the change in population incidence, distinguishing this primary prevention mechanism from secondary and tertiary prevention in terms of the level at which it acts.\n\nReport only the numeric value of $PAF$ as your final answer. Express it as a decimal (not a percentage) and round to three significant figures.",
            "solution": "The problem is assessed to be valid as it is scientifically grounded in established epidemiologic principles, is well-posed with sufficient and consistent data, and is expressed in objective, formal language. We may, therefore, proceed with a solution.\n\nThe objective is to derive an expression for the Population Attributable Fraction ($PAF$) from first principles and then compute its value.\n\nLet $I_{total}$ represent the total incidence of cardiovascular disease (CVD) in the population.\nLet $I_e$ be the incidence of CVD among the exposed group (current smokers).\nLet $I_u$ be the incidence of CVD among the unexposed group (nonsmokers).\nLet $p_e$ be the prevalence of the exposure (smoking) in the population. The prevalence of non-exposure is therefore $1 - p_e$.\n\nFrom first principles, the total incidence in the population is the weighted average of the incidence rates in the exposed and unexposed subpopulations:\n$$I_{total} = I_e \\cdot p_e + I_u \\cdot (1 - p_e)$$\n\nThe relative risk ($RR$) is defined as the ratio of incidence in the exposed group to that in the unexposed group:\n$$RR = \\frac{I_e}{I_u}$$\nThis definition allows us to express the incidence in the exposed group in terms of the incidence in the unexposed group and the relative risk:\n$$I_e = RR \\cdot I_u$$\n\nThe Population Attributable Fraction ($PAF$) is defined as the proportionate reduction in the total population incidence that would occur if the exposure were eliminated. If the exposure were eliminated, a subject who was formerly exposed would acquire the risk of an unexposed subject. Under the problem's assumptions, the entire population's incidence would become $I_u$.\n\nThe absolute reduction in incidence is the difference between the current total incidence and the counterfactual total incidence: $I_{total} - I_u$.\nThe $PAF$ is this reduction expressed as a fraction of the current total incidence:\n$$PAF = \\frac{I_{total} - I_u}{I_{total}}$$\n\nTo derive a computable formula, we express all terms as functions of $p_e$, $RR$, and a baseline incidence $I_u$.\nFirst, substitute $I_e = RR \\cdot I_u$ into the equation for $I_{total}$:\n$$I_{total} = (RR \\cdot I_u) \\cdot p_e + I_u \\cdot (1 - p_e)$$\nFactoring out $I_u$ gives:\n$$I_{total} = I_u (RR \\cdot p_e + 1 - p_e)$$\nThis can be rearranged to $I_{total} = I_u (1 + p_e(RR - 1))$.\n\nNow, we substitute this expression for $I_{total}$ into the definition of $PAF$:\n$$PAF = \\frac{I_u (1 + p_e(RR - 1)) - I_u}{I_u (1 + p_e(RR - 1))}$$\nAssuming $I_u > 0$, we can cancel $I_u$ from the numerator and denominator:\n$$PAF = \\frac{(1 + p_e(RR - 1)) - 1}{1 + p_e(RR - 1)}$$\nThis simplifies to the standard formula for the Population Attributable Fraction:\n$$PAF = \\frac{p_e(RR - 1)}{1 + p_e(RR - 1)}$$\n\nNow, we compute the numeric value of $PAF$ using the given data:\nPrevalence of exposure, $p_e = 0.25$.\nRelative risk, $RR = 2.0$.\n\nSubstituting these values into the derived formula:\n$$PAF = \\frac{0.25(2.0 - 1)}{1 + 0.25(2.0 - 1)}$$\n$$PAF = \\frac{0.25(1.0)}{1 + 0.25(1.0)}$$\n$$PAF = \\frac{0.25}{1.25}$$\n$$PAF = \\frac{1/4}{5/4} = \\frac{1}{5} = 0.2$$\nRounding to three significant figures as requested, the value is $0.200$.\n\nFinally, the problem asks for an explanation of how this relates to levels of prevention. The computed $PAF$ of $0.200$ signifies that $20.0\\%$ of the incidence of CVD in this population is attributable to cigarette smoking. A primary prevention program that completely eliminates smoking would, under the ideal assumptions given, lead to a $20.0\\%$ reduction in the total population incidence of CVD. This is the hallmark of primary prevention: it acts *before* the onset of disease to prevent new cases from occurring by removing or mitigating exposure to causal risk factors.\n\nThis mechanism is distinct from other levels of prevention:\n- **Secondary prevention** acts to detect and treat disease at an early, often asymptomatic stage to slow or halt its progression. For CVD, this would involve screening for and treating conditions like hypertension or hypercholesterolemia. It does not prevent the initial pathological process but aims to avert its clinical manifestation.\n- **Tertiary prevention** acts *after* a disease is clinically manifest and symptomatic. Its goal is to reduce complications, minimize disability, and prevent mortality. For CVD, this would include cardiac rehabilitation programs for patients who have had a heart attack. It focuses on managing an established disease.\n\nThus, the $PAF$ directly quantifies the maximum potential impact of a primary prevention strategy targeting a specific, causal exposure.",
            "answer": "$$\\boxed{0.200}$$"
        },
        {
            "introduction": "Secondary prevention focuses on early detection and treatment, often through screening programs. The effectiveness of a screening test, however, is not absolute and depends critically on the population in which it is deployed. This practice explores the concepts of sensitivity, specificity, and predictive values to demonstrate how a test's Positive Predictive Value ($PPV$)—the probability that a positive result is a true positive—is profoundly influenced by the prevalence of the disease .",
            "id": "4606787",
            "problem": "A public health department is evaluating a screening program for a chronic condition as part of secondary prevention within a comprehensive prevention strategy. Screening performance is characterized by sensitivity, specificity, positive predictive value, and negative predictive value. Consider a binary disease status $D \\in \\{0,1\\}$ and a binary test outcome $T \\in \\{-,+\\}$, and let disease prevalence be $\\pi = P(D=1)$. Derive the population-level expressions for positive predictive value $P(D=1 \\mid T=+)$ and negative predictive value $P(D=0 \\mid T=-)$ from core probability definitions and Bayes theorem. Use the following core definitions:\n- Sensitivity is $P(T=+ \\mid D=1)$.\n- Specificity is $P(T=- \\mid D=0)$.\n- Positive predictive value is $P(D=1 \\mid T=+)$.\n- Negative predictive value is $P(D=0 \\mid T=-)$.\nAssume the test has sensitivity $0.95$ and specificity $0.90$. Compute the positive predictive value when $\\pi = 0.01$ and when $\\pi = 0.10$. Express predictive values as a decimal or a fraction; do not write a percentage sign. Provide your final numerical results only for the two positive predictive values at $\\pi = 0.01$ and $\\pi = 0.10$ in the order given.",
            "solution": "The problem as stated is formally sound, self-contained, and scientifically grounded in the principles of probability theory and epidemiology. All terms are well-defined, and the necessary data for a unique solution are provided. The problem is therefore valid.\n\nWe are asked to derive the population-level expressions for positive predictive value ($PPV$) and negative predictive value ($NPV$) and then to compute the $PPV$ for a given set of parameters. Let the binary disease status be denoted by $D$, where $D=1$ indicates presence of the disease and $D=0$ indicates absence. Let the binary test outcome be denoted by $T$, where $T=+$ is a positive result and $T=-$ is a negative result.\n\nThe core definitions provided are:\nPrevalence: $\\pi = P(D=1)$\nSensitivity: $S_{ens} = P(T=+ \\mid D=1)$\nSpecificity: $S_{pec} = P(T=- \\mid D=0)$\nPositive Predictive Value: $PPV = P(D=1 \\mid T=+)$\nNegative Predictive Value: $NPV = P(D=0 \\mid T=-)$\n\nFrom these, we can state the complementary probabilities:\n$P(D=0) = 1 - P(D=1) = 1 - \\pi$\n$P(T=- \\mid D=1) = 1 - P(T=+ \\mid D=1) = 1 - S_{ens}$\n$P(T=+ \\mid D=0) = 1 - P(T=- \\mid D=0) = 1 - S_{pec}$\n\nThe derivation of $PPV$ and $NPV$ proceeds from Bayes' theorem.\n\nFirst, we derive the expression for $PPV$. By definition, $PPV = P(D=1 \\mid T=+)$. Applying Bayes' theorem, which states $P(A \\mid B) = \\frac{P(B \\mid A)P(A)}{P(B)}$, we have:\n$$PPV = \\frac{P(T=+ \\mid D=1)P(D=1)}{P(T=+)}$$\nThe term in the denominator, $P(T=+)$, is the marginal probability of a positive test result. We can expand this using the law of total probability, conditioning on the disease status $D$:\n$$P(T=+) = P(T=+ \\mid D=1)P(D=1) + P(T=+ \\mid D=0)P(D=0)$$\nSubstituting the defined terms and their complements:\n$$P(T=+) = (S_{ens})(\\pi) + (1 - S_{pec})(1 - \\pi)$$\nSubstituting this back into the expression for $PPV$, we obtain the general formula:\n$$PPV = \\frac{S_{ens} \\cdot \\pi}{S_{ens} \\cdot \\pi + (1 - S_{pec})(1 - \\pi)}$$\n\nNext, we derive the expression for $NPV$. By definition, $NPV = P(D=0 \\mid T=-)$. Applying Bayes' theorem:\n$$NPV = \\frac{P(T=- \\mid D=0)P(D=0)}{P(T=-)}$$\nThe denominator, $P(T=-)$, is the marginal probability of a negative test result, which we expand using the law of total probability:\n$$P(T=-) = P(T=- \\mid D=0)P(D=0) + P(T=- \\mid D=1)P(D=1)$$\nSubstituting the defined terms:\n$$P(T=-) = (S_{pec})(1 - \\pi) + (1 - S_{ens})(\\pi)$$\nSubstituting this back into the expression for $NPV$, we obtain the general formula:\n$$NPV = \\frac{S_{pec} \\cdot (1 - \\pi)}{S_{pec} \\cdot (1 - \\pi) + (1 - S_{ens}) \\cdot \\pi}$$\n\nNow, we are asked to compute the $PPV$ for specific parameter values: sensitivity $S_{ens} = 0.95$ and specificity $S_{pec} = 0.90$. We will perform this calculation for two different prevalence values, $\\pi = 0.01$ and $\\pi = 0.10$.\n\nCase 1: Prevalence $\\pi = 0.01$.\nWe substitute the values into the derived formula for $PPV$:\n$$PPV = \\frac{0.95 \\cdot 0.01}{0.95 \\cdot 0.01 + (1 - 0.90)(1 - 0.01)}$$\n$$PPV = \\frac{0.0095}{0.0095 + (0.10)(0.99)}$$\n$$PPV = \\frac{0.0095}{0.0095 + 0.0990}$$\n$$PPV = \\frac{0.0095}{0.1085} = \\frac{95}{1085} = \\frac{19}{217}$$\n\nCase 2: Prevalence $\\pi = 0.10$.\nWe again substitute the values into the $PPV$ formula:\n$$PPV = \\frac{0.95 \\cdot 0.10}{0.95 \\cdot 0.10 + (1 - 0.90)(1 - 0.10)}$$\n$$PPV = \\frac{0.095}{0.095 + (0.10)(0.90)}$$\n$$PPV = \\frac{0.095}{0.095 + 0.090}$$\n$$PPV = \\frac{0.095}{0.185} = \\frac{95}{185} = \\frac{19}{37}$$\n\nThese calculations demonstrate the critical dependence of predictive values on the prevalence of the condition in the population being tested. Despite the test having constant sensitivity and specificity, the probability that a positive result correctly indicates disease ($PPV$) increases substantially from approximately $8.8\\%$ to approximately $51.4\\%$ as the prevalence increases from $1\\%$ to $10\\%$.",
            "answer": "$$\n\\boxed{\\begin{pmatrix} \\frac{19}{217} & \\frac{19}{37} \\end{pmatrix}}\n$$"
        },
        {
            "introduction": "Deciding when to initiate a primary preventive treatment, such as prescribing statins, involves a careful balancing act between expected benefits and potential harms. This exercise introduces a formal method from decision analysis to determine a rational risk threshold for intervention. By modeling the expected utility, you will derive a clear decision rule that formalizes the trade-offs inherent in preventive medicine, providing a quantitative basis for clinical guidelines .",
            "id": "4380195",
            "problem": "A health system is designing a protocol for initiating statin therapy for primary prevention of Atherosclerotic Cardiovascular Disease (ASCVD) in adults with no prior cardiovascular events. In primary prevention, treatment is offered to reduce the probability of a first event. Let the $10$-year baseline risk of a major ASCVD event for a given patient be $p \\in (0,1)$. Suppose the health system quantifies statin effects using expected value decision analysis, based on the following well-tested principles:\n- Expected value equals the sum over mutually exclusive states of the probability of the state times the payoff of that state.\n- In primary prevention, benefit from statins occurs in those who would otherwise experience the event, while harm occurs in those who would not.\n\nLet $b>0$ denote the expected magnitude of benefit (e.g., reduction in disutility or increase in utility) realized only if the event would otherwise occur, and let $h>0$ denote the expected magnitude of harm (e.g., treatment side effects or inconvenience) realized only if the event would not occur. Model the net expected change in utility from initiating statins, $N(p)$, as the expected value across the two exhaustive states: “event” and “no event.” The health system will initiate statins when the net expected change in utility is nonnegative, and will define a decision threshold $T$ by the indifference condition where $N(T)=0$.\n\nStarting from the fundamental expected value formulation described above, derive a closed-form expression for the threshold $T$ in terms of $b$ and $h$, assuming $b>0$ and $h>0$. Express your final answer as a simplified analytic expression for $T$. If you choose to express $T$ numerically for any specific values, round to four significant figures and express probabilities as decimals without a percent sign. Otherwise, provide the symbolic expression for $T$.",
            "solution": "The problem as stated is scientifically grounded, well-posed, objective, and contains all necessary information for a unique solution. It describes a standard expected value decision analysis, a valid and widely used framework in health economics and medical decision-making. Therefore, I will proceed with the derivation.\n\nThe problem asks for the derivation of a decision threshold, $T$, for initiating statin therapy based on a patient's $10$-year baseline risk of an Atherosclerotic Cardiovascular Disease (ASCVD) event, denoted by $p$. The threshold $T$ is the specific risk at which the net expected utility of treatment is zero.\n\nThe analysis is based on the principle of expected value. The net expected change in utility from initiating statins, $N(p)$, is the sum of the utilities in each possible state, weighted by their respective probabilities. The problem defines two mutually exclusive and exhaustive states for a patient being considered for primary prevention:\n1.  The patient would experience an ASCVD event within $10$ years if not treated. The probability of this state is the baseline risk, $p$.\n2.  The patient would not experience an ASCVD event within $10$ years if not treated. The probability of this state is $1-p$.\n\nThe problem provides the payoffs (changes in utility) associated with initiating statin therapy in each of these states:\n-   If the event would have occurred (State $1$), the patient realizes a benefit of magnitude $b > 0$. The change in utility is $+b$.\n-   If the event would not have occurred (State $2$), the patient realizes a harm of magnitude $h > 0$. The change in utility is $-h$.\n\nUsing the definition of expected value, the net expected change in utility, $N(p)$, can be formulated as:\n$$N(p) = (\\text{Probability of State 1}) \\times (\\text{Payoff in State 1}) + (\\text{Probability of State 2}) \\times (\\text{Payoff in State 2})$$\nSubstituting the probabilities and payoffs defined above:\n$$N(p) = p \\cdot b + (1-p) \\cdot (-h)$$\n\nThis expression can be expanded and simplified:\n$$N(p) = pb - h + ph$$\nFactoring out the variable $p$, we get a linear function of the risk:\n$$N(p) = p(b+h) - h$$\n\nThe health system's policy is to initiate statins when this net expected utility is nonnegative, i.e., when $N(p) \\ge 0$. The decision threshold, $T$, is defined by the indifference condition where the net expected utility is exactly zero. We find this threshold by setting $N(p)$ to $0$ and solving for $p=T$:\n$$N(T) = 0$$\n$$T(b+h) - h = 0$$\n\nTo solve for $T$, we first add $h$ to both sides of the equation:\n$$T(b+h) = h$$\nSince the problem states that $b>0$ and $h>0$, their sum $(b+h)$ must also be positive and therefore nonzero. We can thus divide both sides by $(b+h)$ to isolate $T$:\n$$T = \\frac{h}{b+h}$$\n\nThis is the closed-form expression for the decision threshold $T$ in terms of the magnitude of benefit, $b$, and the magnitude of harm, $h$. This result is dimensionally consistent, as $b$ and $h$ are in units of utility, making the ratio a dimensionless quantity, which is appropriate for a probability threshold. Furthermore, since $b>0$ and $h>0$, it is guaranteed that $0 < h < (b+h)$, which implies that the threshold $T$ will always be in the valid probability range $(0,1)$, consistent with its definition as a risk.",
            "answer": "$$\\boxed{\\frac{h}{b+h}}$$"
        }
    ]
}